Found 0 matching trials
A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic Cancer PHASE2 This is a phase 2 clinical study,to explore the efficacy and safety of Disi...
Show More Location
Multiple Locations
Learn More & Join Trial
Biomarker-Enriched Kidney-Preserving Strategy With Disitamab Vedotin Plus Tislelizumab in HER2-Positive High-Risk Upper Tract Urothelial Carcinoma PHASE2 This is a prospective, multicentre, single-arm phase II study evaluating a ...
Show More Location
Ethics Committee of Shanghai Renji Hospital
Learn More & Join Trial
Real-world Study of HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy N/A The goal of this observational study is to learn about in describe treatmen...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Perioperative Treatment of Hepatoid Adenocarcinoma of Stomach PHASE2 The goal of this clinical trial is to learn if treatment modality including...
Show More Location
Peking University Cancer Hospital & Institute
Learn More & Join Trial
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2) PHASE2 This is a Phase II, randomized, multicenter, open-label clinical trial desi...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
First-line Treatment with RC48 Plus Tislelizumab and S-1(RCTS) in Advanced Gastric Cancer PHASE2 This is a prospective, single arm, multicenter phase II study aimed at eval...
Show More Status
Active Not Recruiting
Location
Central Hospital Affiliated to Shandong First Medical University
Learn More & Join Trial
HERO-UTUC: Intravesical RC48 After RNU for HER2+ UTUC PHASE2 This is a prospective, single-center, single-arm phase II study evaluating ...
Show More Location
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Learn More & Join Trial
Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma PHASE4 A multicenter, open, single arm, phase II clinical trial was designed for m...
Show More Location
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
Learn More & Join Trial
Exploratory Study on the Safety and Efficacy of Disitamab Vedotin in Combination with Anlotinib Hydrochloride for the Treatment of HER-2-expressing Recurrent Platinum-resistant Ovarian Cancer. EARLY_PHASE1 Ovarian cancer is one of the three major malignant tumors of the female rep...
Show More Location
Xiangya Second Hospital of Central South University
Learn More & Join Trial
RC48 Plus AK105 and Cisplatin in Advanced Gastric Cancer PHASE2 To explore the safety and clinical efficacy of cisplatin combined with RC48...
Show More Location
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university
Learn More & Join Trial